Dynport Vaccine Breaks Ground on Frederick Facility
Dynport Vaccine, a joint venture between DynCorp and pharmaceutical company Porton International, has broken ground on a three-story office in Frederick. Dynport Vaccine, the prime systems contractor for the Department of Defense’s vaccine acquisition program, will use the facility to develop biodefense vaccines for FDA production and licensing. The building will consolidate four facilities, as well as providing Department of Defense office space.